Walleye Capital LLC Bio N Tech Se Call Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $1.81 Million - $2.88 Million	23,100 Added 3300.0%	23,800 $2.83 Million
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $618,772 - $792,099	-7,700 Reduced 91.67%	700 $56,000
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $4.86 Million - $6.13 Million	-54,600 Reduced 86.67%	8,400 $774,000
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $5.66 Million - $7.02 Million	62,300 Added 8900.0%	63,000 $6.65 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $226,550 - $287,684	-2,300 Reduced 76.67%	700 $76,000
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $123,096 - $155,592	-1,200 Reduced 28.57%	3,000 $323,000
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $514,794 - $645,414	4,200 New	4,200 $523,000
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $102,120 - $146,488	800 New	800 $108,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.